首页|期刊导航|Hepatobiliary & Pancreatic Diseases International|Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
Wei-Chen Zhang Ke-Yi Du Song-Feng Yu Xue-E Guo Han-Xi Yu Dong-Yan Wu Cheng Pan Cheng Zhang Jian Wu Li-Fang Bian Lin-Ping Cao Jun Yu
Hepatobiliary & Pancreatic Diseases International2025,Vol.24Issue(2):P.157-163,7.
Hepatobiliary & Pancreatic Diseases International2025,Vol.24Issue(2):P.157-163,7.DOI:10.1016/j.hbpd.2024.11.004
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
摘要
关键词
Neoadjuvant therapy/Hepatocellular carcinoma/Major pathologic response/Transarterial chemoembolization/Tyrosine kinase inhibitors/Immune checkpoint inhibitors分类
医药卫生引用本文复制引用
Wei-Chen Zhang,Ke-Yi Du,Song-Feng Yu,Xue-E Guo,Han-Xi Yu,Dong-Yan Wu,Cheng Pan,Cheng Zhang,Jian Wu,Li-Fang Bian,Lin-Ping Cao,Jun Yu..Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization[J].Hepatobiliary & Pancreatic Diseases International,2025,24(2):P.157-163,7.基金项目
supported by grants from the National Natural Science Foundation of China(82270682) (82270682)
the Natural Science Foundation of Zhejiang Province(LQ21H030007 and LQ20H30006)。 (LQ21H030007 and LQ20H30006)